Exploring the genetic interaction between <i>ERAP1</i> / <i>ERAP2</i> and <i>HLA-B*52:01</i> in Takayasu arteritis
These results suggest that the genetic profile of Takayasu arteritis differs from other MHC-I-opathies, supporting its classification as a distinct subtype within this group of immune-mediated diseases. These finding are hypothesis-generating, and validation in larger cohorts is warranted.
Authors
- Amr H. Sawalha (ORCID: https://orcid.org/0000-0002-3884-962X)
- Haner Di̇reskeneli̇ (ORCID: https://orcid.org/0000-0003-2598-5806)
- Enrico Tombetti (ORCID: https://orcid.org/0000-0002-7122-9713)
- Güher Saruhan‐Direskeneli (ORCID: https://orcid.org/0000-0002-6903-7173)
- Peter C. Grayson (ORCID: https://orcid.org/0000-0002-8269-9438)
- Desiré Casares‐Marfil (ORCID: https://orcid.org/0000-0002-4928-3545)
- Lindi Jiang
- Peter A. Merkel (ORCID: https://orcid.org/0000-0001-9284-7345)
Institutions
- National Institutes of Health (US)
- University of Pittsburgh (US)
- University of Milan (IT)
- Fudan University (CN)
- Hospital of the University of Pennsylvania (US)
- Fudan University Shanghai Cancer Center (CN)
- Shanghai Public Health Clinical Center (CN)
- Zhongshan Hospital (CN)
- Mylan (Switzerland) (CH)
- ASST Fatebenefratelli Sacco (IT)
- Istanbul University (TR)
- Marmara University (TR)
- University of Pennsylvania (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1093/rheumatology/keaf544
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00